Adverum Biotechnologies
ADVM
ADVM
83 hedge funds and large institutions have $208M invested in Adverum Biotechnologies in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 14 closing their positions.
Holders
83
Holders Change
-3
Holders Change %
-3.49%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
26
Reduced
22
Closed
14
Calls
$194K
Puts
$4K
Net Calls
+$190K
Net Calls Change
+$113K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$6.51M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$10.8M |
3 |
ACP
3
Acuta Capital Partners
Redwood City,
California
|
$4.82M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$11.1M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$17.3M |